Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05690971

Psychosocial Mobile App for Chronic Graft-Versus-Host Disease

Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Patients With Chronic Graft-Versus-Host Disease (GVHD)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, psychological distress, and coping in patients living with chronic graft-versus host disease (GVHD)

Detailed description

Frequently patients living with chronic GVHD experience physical and emotional symptoms during the course of illness that impacts their quality of life. Patients also often report difficulty managing many of the tasks they need to do to manage their chronic GVHD. They also frequently have a lot of questions about chronic GVHD and the expected trajectory of this illness. The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, and psychological distress in patients with chronic GVHD * This study will randomly assign participants to either receiving Horizons plus usual care or usual care alone. * Enrolled participants will be on the research study for up to sixteen weeks and it is expected that about 120 people will take part in this research study. The Leukemia and Lymphoma Society is supporting this research by providing funding.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAppHORIZONS is self-administered with several features to promote engagement and health behavior change including gamification strategies, videos of chronic GVHD survivors, and optional content. HORIZONS includes five interactive modules to be completed during an eight week period. HORIZONS also includes a sixth optional helpful resources section with a review of the domains and skills covered in the first five modules
BEHAVIORALUsual CarePatients in the usual care group will receive usual care from the transplant oncology team including all the supportive care measures implemented by the transplant oncology team.

Timeline

Start date
2023-01-23
Primary completion
2025-06-01
Completion
2026-06-01
First posted
2023-01-19
Last updated
2025-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05690971. Inclusion in this directory is not an endorsement.